Mutations that Separate the Functions of the Proofreading Subunit of the Escherichia coli Replicase

The dnaQ gene of Escherichia coli encodes the ε subunit of DNA polymerase III, which provides the 3′ → 5′ exonuclease proofreading activity of the replicative polymerase. Prior studies have shown that loss of ε leads to high mutation frequency, partially constitutive SOS, and poor growth. In addition, a previous study from our laboratory identified dnaQ knockout mutants in a screen for mutants specifically defective in the SOS response after quinolone (nalidixic acid) treatment. To explain these results, we propose a model whereby, in addition to proofreading, ε plays a distinct role in replisome disassembly and/or processing of stalled replication forks. To explore this model, we generated a pentapeptide insertion mutant library of the dnaQ gene, along with site-directed mutants, and screened for separation of function mutants. We report the identification of separation of function mutants from this screen, showing that proofreading function can be uncoupled from SOS phenotypes (partially constitutive SOS and the nalidixic acid SOS defect). Surprisingly, the two SOS phenotypes also appear to be separable from each other. These findings support the hypothesis that ε has additional roles aside from proofreading. Identification of these mutants, especially those with normal proofreading but SOS phenotype(s), also facilitates the study of the role of ε in SOS processes without the confounding results of high mutator activity associated with dnaQ knockout mutants.

ABSTRACT The dnaQ gene of Escherichia coli encodes the e subunit of DNA polymerase III, which provides the 39 / 59 exonuclease proofreading activity of the replicative polymerase. Prior studies have shown that loss of e leads to high mutation frequency, partially constitutive SOS, and poor growth. In addition, a previous study from our laboratory identified dnaQ knockout mutants in a screen for mutants specifically defective in the SOS response after quinolone (nalidixic acid) treatment. To explain these results, we propose a model whereby, in addition to proofreading, e plays a distinct role in replisome disassembly and/or processing of stalled replication forks. To explore this model, we generated a pentapeptide insertion mutant library of the dnaQ gene, along with site-directed mutants, and screened for separation of function mutants. We report the identification of separation of function mutants from this screen, showing that proofreading function can be uncoupled from SOS phenotypes (partially constitutive SOS and the nalidixic acid SOS defect). Surprisingly, the two SOS phenotypes also appear to be separable from each other. These findings support the hypothesis that e has additional roles aside from proofreading. Identification of these mutants, especially those with normal proofreading but SOS phenotype(s), also facilitates the study of the role of e in SOS processes without the confounding results of high mutator activity associated with dnaQ knockout mutants.

KEYWORDS
DNA polymerase epsilon subunit linker-scanning mutagenesis mutation rate SOS response The product of dnaQ, the e subunit of Escherichia coli replicative polymerase, DNA polymerase III (Pol III), provides the 39 / 59 exonuclease activity for proofreading function Scheuermann et al. 1983). The protein physically interacts with the a and u subunits, gene products of dnaE and holE, respectively; together, these three subunits comprise the Pol III core. The polymerase activity is in a, whereas the function of u has not been clearly defined beyond binding to e (Studwell-Vaughan and O'Donnell 1993;Slater et al. 1994). In addition to fidelity, e adds structural integrity, increasing the processivity of Pol III in biochemical studies (Studwell and O'Donnell 1990).
e is a 243-amino-acid protein comprising the N-terminal proofreading domain and the C-terminal segment (eCTS) that binds to the a subunit ( Figure 1A). The N-terminal domain (1-186; N186) contains three conserved exo motifs: exo I (8-21), exo II (95-108), and exo IIIe   (Bernad et al. 1989;Blanco et al. 1992; Barnes et al. 1995). Mutational analyses have shown that exo I, exo II, and exo IIIe contain conserved residues that are required for exonuclease activity, and the N186 domain is sufficient for proofreading (Taft-Benz and Schaaper 1998;Perrino et al. 1999). In addition to proofreading function, N186 also contains residues responsible for binding to u (Derose et al. 2003;Keniry et al. 2006). The proposed Q-linker (190-212) of eCTS contains four consecutive glutamines (194)(195)(196)(197) and remains flexible even when bound to a, as determined by NMR spectroscopy (Wootton and Drummond 1989;Ozawa et al. 2008). At the junction of the N-terminal domain and the C-terminal segment, there is a b-clamp binding motif (QTSMAF at amino acids 182-187) (Jergic et al. 2013). The b-clamp binding motif is responsible for the e-b interaction of the tripartite complex comprising a, e, and b (Toste Rego et al. 2013). Additionally, there is a poorly mapped site for chaperone DnaK binding within the eCTS (Bressanin et al. 2009).
Various dnaQ mutant alleles have been discovered or created, many of which, including dnaQ49 and mutD5, generate an extremely high mutator phenotype (Degnen and Cox 1974;Horiuchi et al. 1978;Echols et al. 1983;Fijalkowska and Schaaper 1996). MutD5 (T15I) is an extreme mutator, with mutation frequencies up to 3000-fold higher than wild-type levels using rifampicin resistance as a measure (Degnen and Cox 1974;Schaaper 1988;Fijalkowska and Schaaper 1996). DnaQ49 (V96G) is a recessive, temperature-sensitive mutant with negligible mutator activity at 28-30°but high mutator activity at 37° ( Horiuchi et al. 1978;Echols et al. 1983). The e proteins encoded by these two mutants differ in their ability to associate with a and, hence, the Pol III core (Takano et al. 1986). Cells carrying extreme mutator alleles of dnaQ are not viable, at least in part because of loss of proof-reading, which leads to massive misincorporation and overload of the mismatch repair system (Schaaper 1989;Schaaper and Radman 1989;Fijalkowska and Schaaper 1996). However, the extreme increase in mutation frequency facilitates the rapid acquisition of suppressor mutations in dnaE (encodes a), which alleviate the growth defect and reduce the mutator phenotype (Lancy et al. 1989;Schaaper and Cornacchio 1992;Fijalkowska and Schaaper 1995).
In addition to the mutator phenotype, dnaQ mutants also display a partially constitutive SOS phenotype and an increased frequency of direct repeat recombination (Lifsics et al. 1992;Slater et al. 1994;Saveson and Lovett 1997). Although these phenotypes can be rationalized as being caused by loss of proofreading function, they may instead (or in addition) relate to the effects of e on the behavior (e.g., processivity) of DNA polymerase (for example, see discussion by Saveson and Lovett 1997). Previous studies in our laboratory uncovered an unexpected connection between e and quinolone-induced DNA damage in E. coli. Quinolones are a broad-spectrum antibiotic class that target type II topoisomerases and lead to inhibition of DNA synthesis. There are numerous quinolone derivatives, including members of the more potent subclass known as fluoroquinolones. There are also variations on the detailed mechanism of drug action, depending on the particular structure of the quinolone derivative and the cellular conditions (Drlica et al. 2008). Quinolones, including the parent compound nalidixic acid, target DNA gyrase in E. coli, stabilizing the so-called cleavage complex in which gyrase is covalently attached to the two newly cleaved 59 ends of DNA in the strand-passage reaction intermediate. These stabilized cleavage complexes (SCCs) are reversible and their presence is necessary, but not sufficient, for cell death. Genetic evidence implies that quinolone cytotoxicity depends on formation of chromosomal double-strand breaks; however, the mechanism(s) of break formation is still unclear and the cytotoxic breaks may not be the breaks within the SCC (for review, see Drlica et al. 2008). The strongest evidence relates to the importance of RecBCD protein, which requires DNA ends to act. RecBC knockout mutants are hypersensitive to nalidixic acid treatment (McDaniel et al. 1978), implying that RecBC-dependent recombination rescues quinolone-induced breaks. Also, SOS induction following nalidixic acid treatment requires RecBCD enzyme, which processes broken ends and facilitates RecA loading for induction of the damage response (McPartland et al. 1980). Direct evidence of chromosome fragmentation after quinolone treatment was uncovered using sedimentation analysis and supercoiling assays (Steck and Drlica 1984).
A transposon insertion screen to identify mutants defective in SOS induction following nalidixic treatment returned 18 mutants, all of which were recB or recC mutants (Newmark et al. 2005). This study confirmed the RecBC-dependent nature of quinolone-induced SOS response, but failed to uncover any novel mutants. However, this screen would likely have missed mutants that were partially SOS constitutive. A subsequent screen of SOS constitutive transposon mutants revealed dnaQ mutants with a substantial but incomplete defect in SOS induction following quinolone treatment (Pohlhaus et al. 2008). This was not a general SOS defect, because the mutants were capable of RecFOR-dependent SOS induction (after treatment with mitomycin C). The dnaQ transposon insertion mutants therefore exhibited an SOS profile similar to recBC mutants, implicating e in the mechanism of double-strand break formation after nalidixic acid treatment. Our hypothesis is that this e role in double-strand break formation is not related to exonuclease activity, but rather reflects some function of e in replication fork stability that is critical for how the fork responds to the quinolone-induced cleavage complexes, which have been shown to block replication forks in vivo .
The hypothesis above predicts that e performs multiple functions, which should be mutationally separable. Isolation of separation of function mutants would substantiate the hypothesis and could also provide a very valuable reagent-a non-mutator (stable) dnaQ mutant with SOS phenotypes. In this study, we introduced small perturbations throughout the dnaQ sequence using pentapeptide linker-scanning mutagenesis. This procedure introduces variable five-amino acid cassettes, as well as a subset of small insertions with stop codons, randomly throughout the sequence of a gene, and has proven effective in the separation of phenotypes for multi-functional proteins XerD and McrA (Cao et al. 1997;Anton and Raleigh 2004). Five-amino-acid insertions anywhere in the coding sequence can potentially cause separation of function, whereas stop codon insertions toward the C terminus might be expected to create partially functional truncation proteins. Our results show that the proofreading function of e can be uncoupled from the SOS phenotypes. We also isolated insertion mutants that separate partially constitutive SOS and defective nalidixic acid-induced SOS phenotypes, as well as a mutationally stable dnaQ allele with SOS phenotypes. Overall, our results implicate e-dependent replisome behavior in the bacterial response to nalidixic acid.

Linker scanning mutagenesis
Mutagenesis was performed with the New England Biolabs GPS-LS system according to provided instructions. Plasmid pMM5Z was created by digesting pMM5 with AatII restriction enzyme and annealing oligos BglII #1 (59-TGAGATCTCCGCAACGT-39) and BglII #2 (59-TGCGAGATCTCAACGT-39). The transposon reaction of plasmid pMM5Z (see Table 1) was electroporated into DH5a using a Bio-Rad Gene Pulser according to the manufacturer instructions, selecting for insertion mutants on plates with chloramphenicol and ampicillin. After overnight incubation at 37°, 1017 colonies were collected and pooled into the primary mutant library. Generating the dnaQ mutant library Plasmid DNA from the primary library of 1017 colonies (see Table 1) was digested with PstI and DraIII. Fragments containing the dnaQ gene along with the 1376-bp transposon insertion were separated by gel electrophoresis and extracted. The extracted fragments were ligated to fresh PstI/DraIII-cleaved pMM5Z vector and electroporated into DH5a (selecting again with chloramphenicol and ampicillin). The colonies were pooled and a secondary plasmid library was generated and extracted. The secondary plasmid library was digested with PmeI, gel-purified, and re-ligated-these steps remove the majority of the transposon, leaving behind a 15-bp insertion with a single PmeI site. The desired products were isolated by transformation into DH5a. The plasmid library was harvested and then the final dnaQ insertion mutant library was subcloned into the polylinker of pMAK705 using ClaI and PstI sites that flank the dnaQ gene.

Gene replacement
Following the method of Hamilton et al. (1989), we incorporated insertion and site-directed mutations into the chromosome of JH39 at the native location of dnaQ. This method uses plasmid pMAK705, with its temperature-sensitive replicon, to facilitate incorporation into the chromosome. Plasmid pMAK705 containing a dnaQ allele can integrate into the dnaQ region of the chromosome by homologous recombination, and integrants are selected on chloramphenicol plates at the nonpermissive temperature (44°). Selection is then relieved by growth at the permissive temperature (30°), which favors segregants that lose the plasmid from the chromosome. Chloramphenicol-sensitive segregants were screened for those with the desired dnaQ in the chromosome via PCR amplification using chromosome-specific primers dnaQ5F (59-TGCCCCAAAACGAAGGCAGT -39) and dna-QI3R2 (59-TGCAGCCACAAAACGCAGTG -39). PCR products were digested with PmeI and sequenced using primers dnaQseq1 (59-ACCGCTCCGCGTTGTGTTCC-39) or dnaQseq2 (59-CGGTTG TTGGTGGTGCGGGT-39).
Quantitative b-galactosidase assay The convenient dinD::lacZ reporter allows monitoring of SOS in the JH39 strain. SOS levels were determined using a b-galactosidase protocol modified for 96-well microtiter plates (Thibodeau et al. 2004).
Overnight cultures were diluted 1:100 in LB and grown for 2 hr. They were then treated with nalidixic acid (10 mg/ml) or no drug and incubated for an additional 2 hr. Cell density (A 630 ) was measured and 100 ml of each culture was lysed with Novagen PopCulture reagent at room temperature. A 15-ml aliquot of lysed cells was incubated with 135 ml Z-Buffer (40 mM Na 2 HPO 4 , 60 mM NaH 2 PO 4 , 10 mM KCl, 1 mM MgSO 4 ), 0.5 ml TCEP [Tris (2-carboxyethyl) phos-phine], and 30 ml of 2-Nitrophenyl b-D-galactopyranoside (4 mg/ mL). The accumulation of 2-nitrophenol product was measured at A 405 for 60 min. Miller units were calculated using the modified equation (V Ã 1000 Ã CF1 Ã CF2)/(A 595 Ã CF3 Ã relative volume of cell lysate used). CF1, CF2, and CF3 are conversion factors that account for absence of Na 2 CO 3 , A 415 to A 420 , and A 595 to A 600 , respectively (making this equation comparable to that of Miller). This method assesses the rate of b-galactosidase accumulation over time and is therefore more accurate than simple endpoint measurement b-galactosidase assays.

Mutation rate measurements
The rifampicin-resistant colony-forming units of at least eight independent overnight cultures and the total colony-forming units of at least three overnight cultures were measured. The mutation rate of each strain was calculated using the Lea Coulson Method of the Medians Fluctuation Analysis Calculator (FALCOR) program (Foster 2006).

Generation of dnaQ mutants
To determine if the multiple phenotypes of a dnaQ mutant are separable, we used the GPS-LS Mutagenesis kit (NEB) to create a plasmid library of dnaQ insertion mutants. This system introduces a 1376-bp transposon randomly throughout the target sequence. Subsequent digestion with PmeI excises the majority of the transposon, leaving behind a 15-bp segment that encodes a 5-codon insertion and, in a subset of cases, one of the five codons is a stop codon that generates truncations in the protein.
Our general strategy involved sequencing the sites of insertion in a number of plasmid-borne dnaQ alleles, and then selecting a subset to move into the chromosome and replace the native dnaQ gene ( Table 2). The subset was selected based on available structural, biochemical, and genetic data in the literature. We included insertions within both the N186 domain and the CTS. Insertions within the N-terminal domain were selected based on structural considerations (Protein Database ID: 2XY8 and 2GUI) (Berman et al. 2000); we chose locations that seemed less likely to greatly disrupt protein structure and proofreading/exonuclease function. Thus, we avoided highly conserved residues and chose targets on the outer surfaces of the protein rather than buried in the core. We also included two insertion/truncations, one of which (at residue 132) likely generates a complete knockout as a reference for loss of function. The other (at residue 224) creates a truncation in the CTS, which might possibly compromise a function involved in replication fork behavior without affecting proofreading function.
In addition to insertion mutants, we generated three site-specific mutants based on prior studies of dnaQ. First, we recreated a moderate mutator allele, dnaQ928. This allele behaves as a dominant mutation and alters the exo I motif (G17S), indicating that it retains the ability to associate with a (Taft-Benz and Schaaper 1998). We also regenerated two interesting mutations that have been shown to effect binding of b-clamp in vitro (Jergic et al. 2013). These authors characterized a b-clamp binding motif within e, QTSMAF, at position 182-187, and generated strong (QLSLPL) and weak (ATSMAF; Q182A) binding alleles. Interestingly, they showed that a stronger b-clamp interaction with e led to a more stable and processive Pol III core; therefore, these mutants are expected to alter replisome behavior and might affect SOS phenotypes.
The desired subset of insertion mutations (Table 2) and the sitespecific mutations were moved onto the chromosome, replacing the native dnaQ in the correct location and with the natural sequences for gene expression and regulation. We focused on chromosomal constructs because prior experiments revealed conflicting results when dnaQ mutants were expressed from a plasmid in comparison to expression from the chromosome, indicating that aberrant gene expression from the plasmid was a confounding issue (data not shown). Chromosomal gene replacement was achieved using plasmid pMAK705, a temperature-sensitive plasmid with chloramphenicol resistance (Hamilton et al. 1989). The dnaQ mutant fragment was cloned into the polylinker of pMAK705 and substituted into the chromosome of parental strain JH39 (see Materials and Methods). Chromosomal mutant segregants that completely lack the substitution plasmid were confirmed by lack of chloramphenicol resistance and by sequencing chromosomal PCR products that contained the mutant dnaQ allele. Additionally, the dnaE gene of each insertion and sitedirected mutant was sequenced in its entirety to check for possible suppressor mutations. Although the sequencing confirmed each dnaE gene as wild-type, we cannot exclude the possibility of suppressor mutations elsewhere in the genome.

Phenotypes of dnaQ mutants
Proofreading activity of dnaQ was assessed using the well-established rifampicin resistance assay as a measure of mutation rate. At least eight independent cultures of each strain were grown overnight and appropriate dilutions/aliquots were plated on LB agar with and without rifampicin, and the frequency of rifampicin resistant over total colony forming units was calculated. Mutation rates were then calculated using the Lea Coulson Method of the Medians (see Materials and Methods) (Foster 2006). SOS phenotypes were determined using a high-throughput b-galactosidase assay in microtiter plates, measuring both constitutive SOS levels and the ability of the mutants to induce SOS following nalidixic acid treatment. All mutation and SOS measurements are summarized in Table 3.
To analyze the relationships between phenotypes of the various mutants and compare them to wild-type and a dnaQ deletion mutant, we plotted phenotypes in pairs. First, we compared mutation rates to basal SOS levels as a measure of proofreading activity (Figure 2). The mutation rates were also compared to the increase in SOS levels with nalidixic acid treatment (DNalidixic acid) (Figure 3). Finally, the basal SOS levels were compared to the DNalidixic acid levels to look for possible separation of SOS functions (Figure 4).
In the first two comparisons, we aligned all mutants according to decreasing mutation rate from left to right (Figure 2, Figure 3). Although somewhat arbitrary, the mutants roughly fall into three categories (separated by dotted lines left to right): high mutator (like DdnaQ; red bar); moderate mutator [like dnaQ928 (G17S)]; and non-mutator (like WT; green bar). The lowest median mutation rate of the moderate mutator group is 11-fold higher than wild-type, whereas the lowest median mutation rate in the high mutator group is more than 225-fold higher than wild-type. Three of the mutants in the right "nonmutator" category appeared to have a slight elevation (2-fold to 5-fold) of mutation rate compared to the wild-type; these include the two site-directed mutants in the b-clamp binding motif (Q182A and QLSLPL) as well as insertion mutant 162 LFKQL.

Insertions that behave like wild-type
Wild-type strains that are dnaQ + are nonmutators, are not SOS constitutive, and respond to nalidixic acid treatment with high levels of SOS induction. Insertions 115 KLFKH, 125 LFKHF, and 196 LFKQQ behave in this way (Figure 2, Figure 3), indicating that these insertions are innocuous for all e functions and for important structural features of the protein. The insertion at residue 115 is at the end of a helix 4 and between motifs exo II and exo IIIe, on the outside surface of the protein. The 125 LFKHF insertion is also between these two motifs at the end of the a helix, but before b sheet 5. Insertion 196 LFKQQ is within the four consecutive glutamines of the Q-linker region (but does retain two runs of three glutamines). NMR studies of eCTS determined that the Q-linker region and especially the stretch of four glutamines are highly flexible; therefore, the flexible nature of this region might possibly make it tolerant to insertions or other alterations.

Insertions that behave like DdnaQ
Complete knockout of e leads to high mutation rate, partially constitutive SOS, and failure to induce SOS following nalidixic acid treatment. Mutants that behave in this way include 30 IICLN, 79 CLNTF, 97 ILFKQ, 224 AHV Ã , 232 LFKQV, and 132 V Ã (Figure 2, Figure 3). Although the insertion at 30 is not within the conserved exo I or exo II motifs, it is at the core of the protein on b-strand 2, which seems likely to disrupt protein folding (Hamdan et al. 2002). The truncation 132 V Ã eliminates much of the exo IIIe motif and the entire C-terminal segment; again, it is not surprising that it abolishes all e function. Insertion 97 ILFKQ maps very close to the conditionally lethal mutator dnaQ49 (V96G). Both mutations are within the e exo II motif, and dnaQ49 has been shown to be recessive and encode an e that cannot bind to a (Takano et al. 1986;Jonczyk et al. 1998). The insertion mutant 79 CLNTF, located between exo I and exo II, may disrupt protein stability as it is located in a helix 3, which comprises the active site along with a helix 7 and the edges of b sheets 1-3 (Hamdan et al. 2002).
The eCTS associates with the a subunit, and the two proteins can be cross-linked via residue 235 in the eCTS (Perrino et al. 1999;Taft-Benz and Schaaper 1999;Ozawa et al. 2008;Toste Rego et al. 2013). Residues 218-237 form an a helix (Ozawa et al. 2013), which is the site of insertion mutant 232 LFKQV. Given the location of this insertion, outside of the proofreading NTD, we surmise that it either disrupts the ability of e to bind to a or results in an unstable protein.
n A similar inference seems likely for insertion mutant 224 AHV Ã , which truncates the eCTS, including the aforementioned a helix.

Proofreading can be uncoupled from SOS phenotypes
We next turn to several apparent separations of function mutants that were uncovered. When comparing mutation rates to the basal (no drug) SOS levels, most of the mutants behaved similarly to wild-type or similarly to the e knockout, or were somewhere in between as partially functional mutants would do (Figure 2). We found no mutants with complete separation of function, namely high mutator/low basal SOS or low mutator/partially constitutive SOS (far left and far right of Figure 2, respectively). However, a number of mutants did exhibit moderate mutator activity (reduced proofreading) yet showed wild-type levels of basal SOS expression (middle of Figure  2): G17S (dnaQ928); 76 CLNNK; 143 NSCLN; 228 CLNKA; and 57 LVFKQ. Although G17S and 143 NSCLN are in motifs exo I and exo IIIe, respectively, the other insertions are not within the conserved residues related to proofreading. Insertion 57 LVFKQ lies between motifs exo I and exo II; therefore, the behavior of this mutant aligns with a report that implicates this region for full proofreading function (Taft-Benz and Schaaper 1998). The moderate mutator phenotype of mutant 228 CLNKA, which has an insertion within the eCTS a helix, could reflect altered binding of e to a (see above). Mutants with moderate mutator but low basal SOS could be explained by two models: (1) SOS is induced only by extreme levels of misincorporation or (2) the two phenotypes are caused by two different functions of e. Further experiments are necessary to distinguish between these two models. It is worth noting that the SOS constitutive phenotype of e knockout mutants is rather modest (dinD::lacZ expression increased by only approximately 50%; see Ta Considering the relationship between proofreading and the ability to induce SOS after nalidixic acid treatment, many of the mutants again behaved like either wild-type or the e knockout mutant, or somewhere in between as partially functional mutants might do (Figure 3). However, we found two striking separation of function mutants-insertion mutants 208 VFKHQ and 143 NSCLN (Figure 3).
Insertion mutant 208 VFKHQ displayed fully functional proofreading but no ability to induce SOS after nalidixic acid exposure ( Figure  3). This insertion is within the eCTS, outside of the proofreading domain. Because the proofreading function appears normal, the insertion presumably does not abolish the interaction of a with eCTS (although it may alter the consequences of the interaction; see Further discussion). Mutant Q182A has a somewhat similar phenotype to 208 VFKHQ and is discussed below.
Insertion mutant 143 NSCLN shows a different kind of separation of function, with a 22-fold increase in mutation rate but a robust ability to induce SOS following nalidixic acid exposure (Figure 3). This mutant has an insertion within Exo IIIe, consistent with its mutator phenotype. The ability of the 143 NSCLN mutant to induce SOS after nalidixic acid treatment indicates that the insertion does not disrupt whatever interaction is necessary for this function (see Further discussion). 143 NSCLN mutant appeared to induce somewhat higher levels of SOS with nalidixic acid treatment than the wild-type. Likewise, insertion mutant 162 LFKQL, with a nearly wild-type mutation rate, induced SOS after nalidixic acid at a level that was significantly (74%) higher than that of the wild-type (P = 0.0064). These two mutants appear to generate a novel phenotype of dnaQ mutants hyper-responsive to nalidixic acid-induced cleavage complexes (see Further discussion).

Relationship of constitutive SOS to nalidixic acid-induced SOS
We next discuss the comparison of basal SOS levels with the increase in SOS following nalidixic acid treatment; in this regard, the mutants scattered widely (Figure 4). Considering mutants with little or no ability to induce SOS following nalidixic acid treatment, phenotypes ranged from basal SOS similar to wild-type (Q 182 A, 76 CLNNK, and 208 VFKHQ; separation of function for SOS) to significantly higher n constitutive levels than the e knockout ( 30 IICLN and 232 LFKQV). We also identified partially constitutive mutants that are able to induce SOS following nalidixic acid treatment ( 162 LFKQL and QLSLPL; discussed above and below, respectively).

Site-directed mutants
The b-clamp binding mutants appear to be separation of function alleles. QLSLPL, the strong b-clamp binding mutant, retains catalytic proofreading function as expected but showed a basal SOS level significantly higher than wild-type (P = 0.0000134) and closer to the e knockout ( Figure 2; Table 3). This mutant also demonstrates separation of SOS phenotypes, because it shows a robust induction of SOS with nalidixic acid treatment ( Figure 4; Table 3). This mutant e was shown to have a stronger e-b interaction than wild-type (Jergic et al. 2013), which could provide a barrier to dissociation of the replisome on encounter with endogenous damage, potentially elevating basal SOS (see Further discussion).
The weak b-clamp binding mutant, Q182A, revealed a particularly interesting collection of phenotypes. It demonstrated weak mutator activity (approximately five-fold higher mutation rate than that of wild-type), along with a basal SOS level that was significantly lower than that of wild-type (P = 0.0042) and greatly reduced induction of SOS following nalidixic acid treatment. These results implicate the e-b clamp interaction in the SOS phenotypes caused by the absence of e (see Further discussion).

Further discussion
The multiple phenotypes of dnaQ knockout mutants are consistent with the possibility that e has multiple functions. This possibility was raised decades ago, supported by the isolation of suppressor mutations within dnaE that reverse the growth deficiency but not the proofreading defect of a dnaQ mutant (Lancy et al. 1989;Lifsics et al. 1992). The isolation of separation of function mutants in this report strongly supports the proposal of multiple e functions (Table 4). Certain separation of function mutants isolated here also provide a very useful reagent, namely e variants with defects in functions relating to SOS induction but wild-type mutation rates, i.e., mutationally stable strains that do not produce confounding results due to spurious global mutations. Our data also identify sites in e (residues 115, 125, 196) that are tolerant of five amino-acid insertions with no phenotypic consequence.
These results can be viewed through the lens of recent studies on the clamp binding motif of e and the interactions between clamp, e, and a (Jergic et al. 2013;Toste Rego et al. 2013). Toste Rego et al. (2013) analyzed the interactions of the three proteins, demonstrating that e enhances the stability of the clamp-a complex and identifying sites where each pair of proteins can be cross-linked to each other. The increase in stability of the complex due to e binding is presumably related to the stimulation of polymerase processivity by e (Studwell and O'Donnell 1990;Kim and Mchenry 1996), and clamp binding by e, in turn, improves proofreading ability (Toste Rego et al. 2013). Based on these and other results, Toste Rego et al. (2013) developed a model in which a and e simultaneously bind to the canonical binding pocket of the two protomers of the b clamp dimer. Importantly, they also identified cross-links between a and both the proofreading NTD of e and the extreme e C-terminus (residue 235). These results led to an elegant model for how the polymerase complex responds to both template damage and misincorporation.
As mentioned above, misincorporated bases are more efficiently proofread by e in the context of the tripartite complex. Template damage, however, cannot be corrected by e, but rather is proposed to cause weakening of the clamp-e interaction, which can allow binding of the translesion polymerase Pol IV. One important feature of the model is that e remains associated with a via the flexible eCTS even when the e-clamp association is lost. Several aspects of this model could relate to the phenotypes of e mutants analyzed here, and we propose that the dynamic behavior of the tripartite complex described above could directly relate to the response of the replisome to endogenous lesions and to blocking gyrase cleavage complexes.
As the tripartite complex encounters endogenous damage, the weak clamp binder (Q 182 A) would be expected to more readily dissociate from the clamp, allowing translesion polymerases to access the free site on the b clamp. Q 182 A has weak mutator activity (five-fold higher than wild-type), and we propose two mechanisms that could lead to this. One scenario is that Q182A has weaker exonuclease activity, and this leads to less efficient proofreading, hence the weak mutator activity observed. The other scenario is that the weak binder allows Pol IV to access the b clamp more often, with or without a lesion present. Pol IV is a low-fidelity polymerase, and this occasional access could be the cause of the weak mutator activity. If the weak clamp binder allows the translesion polymerase to associate more easily, it could synthesize past the lesion and dissociate, then Q 182 A e (still bound to a) would regain access to the clamp to continue high-fidelity replication without inducing SOS. More efficient TLS across the endogenous template damage is thus proposed to reduce basal SOS levels, which is observed for Q 182 A.
Under these same assumptions, the strong clamp binder, QLSLPL, would remain bound to the b clamp, preventing access by the translesion polymerase. This mutant would not easily allow the translesion polymerase to access the b clamp. This is consistent with the mutation rate similar to that of wild-type observed with this mutant. When facing endogenous damage, the replication fork with e tightly bound to a would stall, because the translesion polymerase does not have access to the b clamp in QLSLPL and the damage could not be readily bypassed. This prolonged polymerase stalling could result in increased SOS induction, explaining the constitutive SOS phenotype of QLSLPL.
Our results indicate that the e-b clamp interaction is required for nalidixic acid-induced SOS, such that the weak clamp binder leads to defective SOS induction following nalidixic acid. These results are consistent with a particular version of the replication run-off model. We know that quinolone-induced SCCs cause replication fork stalling, and stalling presumably leads to DnaB helicase unloading. We Figure 3 The D nalidixic acid SOS levels and mutation rate. The D nalidixic acid SOS levels (bars) represent the difference between 6 nalidixic acid samples (note position of D nalidixic acid = 0 on the Y axis) and are indicated by b-galactosidase activity corresponding to the left axis. Mutation rate (h) corresponds with the right axis. The D nalidixic acid SOS error bars indicate SE and mutation rate error bars represent the upper and lower 95% C.I.s. Samples are sorted by decreasing mutation rate. Wild-type is green and DDnaQ is red.
propose that the tripartite polymerase complex usually cannot proceed to the SCC at this stage, but occasionally moves forward, encountering and disrupting the SCC. The resulting broken arm of the replication fork creates a double-stranded end for RecBC to resect, which in turn is recognized by RecA for SOS induction.
As outlined above, the weak clamp mutant (Q182A) more easily allows translesion polymerases to associate with the tripartite complex. We propose that this weaker, less-processive tripartite complex would not have the ability to move forward and disrupt the SCC. Thus, the weak clamp binder does not create a break or double-strand end for RecBC, leading to the defect in nalidixic acid-induced SOS.
With the strong clamp-binding mutant (QLSLPL), the tripartite complex is tightly associated, showing even higher processivity than the wild-type complex (Jergic et al. 2013). According to this model, this mutant complex moves forward efficiently, readily disrupting the SCC and thereby generating double-strand ends and inducing SOS efficiently (equal to or perhaps slightly higher than wild-type; see Figure 3).
In this model, an e knockout causes a defect in nalidixic acidinduced SOS response because e is required for sufficient processivity to disrupt the SCC. In several of our SOS-defective insertion mutants ( 30 IICLN, 79 CLNTF, 132 V Ã , 224 AHV Ã , and 232 LFKQV), the high mutators are likely knockouts due to protein instability, misfolding, and/or inability to associate with a at the tripartite complex, eliminating all functions of e.
This replication run-off model can explain some of the striking separation of function mutants. For example, 162 LFKQL behaves sim-ilar to the strong clamp binder; it is a low mutator (consistent with preventing Pol IV access to the clamp), SOS constitutive, and able to induce SOS after nalidixic acid at levels even higher than that of wildtype. Like the weak b-clamp mutant Q182A, 76 CLNNK has modestly higher mutation rate and lower nalidixic acid-induced SOS levels than the wild-type (with basal SOS levels in between those of Q182A and wild-type). Biochemical characterization of these various dnaQ mutants could directly test whether they affect the tripartite complex as predicted and whether disruption of the SCC occurs in the manner predicted by the replication run-off model. Figure 4 Basal and D nalidixic acid SOS levels. Basal b-galactosidase activity (bar) graphs to the left axis and D nalidixic acid values (s) to the right axis (difference between nalidixic acid SOS level and basal SOS level; note the position of 0 on Y axis). Error bars represent SE. Samples are sorted by increasing basal SOS levels. Wild-type is green and DDnaQ is red. n